Sate Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Dehradun, Uttarakhand, India, established in 2007.
2007 Dehradun, Uttarakhand, India Struck Off
Last Updated:
Access Report
About Sate Pharma Private Limited

Sate Pharma Private Limited, a struck off private limited company, was established on 29 May 2007 in Dehradun, Uttarakhand, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232UR2007PTC032415. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.40 M.

Its leadership includes Vinod Dobhal (Director), Sudha Jhildiyal (Director). Past directors included Balwant Singh Bisht. Its latest AGM occurred on 24 May 2011, with the balance sheet filed on 31 March 2011. It is based at Badripur Badripur Road, Jogiwala, Dehradun, Uttarakhand, 248001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UR2007PTC032415

  • Registration Number

    032415

  • Incorporation Date

    29 May 2007

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹0.40 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 0.40 M
  • Company Age 18 Year, 8 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Sate Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sate Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sate Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Vinod Dobhal Director 29 May 2007 Current
Sudha Jhildiyal Director 29 May 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sate Pharma.

Enhance accessibility to Sate Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sate Pharma revenue growth over time
Sate Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sate Pharma?

Unlock access to Sate Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sate Pharma?

Unlock and access historical data on people associated with Sate Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sate Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sate Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sate Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sate Pharma Private Limited last Annual general meeting of members was held on 24 May 2011 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Sate Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Uttarakhand. was completed.

  • Director Appointment

    Progress on Vinod Dobhal was appointed as a Director was appointed as a Director on 29 May 2007 & has been associated with this company since 18 years 8 months . was documented.

  • Director Appointment

    The activity Sudha Jhildiyal was appointed as a Director was appointed as a Director on 29 May 2007 & has been associated with this company since 18 years 8 months . was completed.

  • Company Incorporation

    Sate Pharma Private Limited was registered on 29 May 2007 with Roc Uttarakhand & aged 18 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sate Pharma Private Limited?

The CIN of Sate Pharma Private Limited is U24232UR2007PTC032415.

Where is Sate Pharma Private Limited headquartered?

Sate Pharma Private Limited is headquartered at Badripur Badripur Road, Jogiwala, Dehradun, Uttarakhand, 248001.

When was Sate Pharma Private Limited incorporated?

Sate Pharma Private Limited was incorporated on 29 May 2007.

Who are the current directors of Sate Pharma Private Limited?

The current directors of Sate Pharma Private Limited are

What is the primary industry of Sate Pharma Private Limited?

The primary industry of Sate Pharma Private Limited is Chemicals.

Is Sate Pharma Private Limited a listed company?

Sate Pharma Private Limited is unlisted.

What is the capital structure of Sate Pharma Private Limited?

The authorized capital of Sate Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹0.40 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available